cGMP modulates hemin-mediated platelet death
Anne‐Katrin Rohlfing(University of Tübingen), Meinrad Gawaz(University of Tübingen), David Schaale(University Children's Hospital Tübingen), Oliver Borst(Thrombosis Research Institute), Zoi Laspa(University Children's Hospital Tübingen), Tatsiana Castor(University of Tübingen), Christoph Trautwein(Siemens (Germany)), Marcel Kremser(University Children's Hospital Tübingen), K. Müller(University Children's Hospital Tübingen), Laimdota Zizmare(Siemens (Germany)), Manuel Sigle(University of Tübingen), Tobias Harm(University Children's Hospital Tübingen), Robert Feil(University of Tübingen), Valerie Dicenta‐Baunach(University of Tübingen), Xiaoqing Fu(Yunnan Center for Disease Control And Prevention), Patrick Münzer(Thrombosis Research Institute), Michael Lämmerhofer(University of Tübingen), Andreas Pelzer(University Children's Hospital Tübingen)
Cited by 13
Related Papers
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
|Cellular Physiology and Biochemistry|2013|1.9k
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617
Platelet-derived HMGB1 is a critical mediator of thrombosis
|Journal of Clinical Investigation|2015|374
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM
|Cytotherapy|2006|245
Impaired insulin secretion and glucose tolerance in β cell‐selective CaV1.2 Ca2+ channel null mice
|The EMBO Journal|2003|236